In a zebrafish model of mitochondrial dysfunction and age-related retinal degeneration, 14 days of oral Telomir-Zn improved three measures of visual function, restored retinal layer thickness, and lowered oxidative stress markers. Telomere content and selected age-associated DNA methylation patterns also shifted toward those of healthy animals, with the company attributing the effect to increased intracellular zinc and reduced reactive iron. The work is preclinical, company-announced, and includes no human eye-disease data.
Key Points
- Oral compound restored visual tracking, light adaptation, retinal layer thickness in zebrafish
- Telomere content and age-linked methylation patterns moved toward healthy profiles
- Preclinical, company-reported; oxidative stress measured in brain, not retina
Longevity Analysis
Intracellular metal balance sits upstream of several aging processes at once: reactive iron drives oxidative damage, and iron-dependent demethylase enzymes shape which genes remain active. A compound that shifts the zinc-to-reactive-iron ratio therefore touches energy production, tissue repair and epigenetic regulation simultaneously, which is why a single intervention produced changes in both vision and aging markers. The limitation is equally instructive — oxidative stress was read from brain tissue rather than the retina itself, a reminder that a measured signal and the tissue of interest are not always the same thing.
Original published by Longevity.Technology, by Kyle Umipig.